Stealth’s Forzinity: Barth Syndrome Drug’s Uncertain Efficacy Split US FDA

 
• By Sue Sutter
  
DRP Forzinity main image
The FDA granted accelerated approval to Stealth's Barth syndrome drug Forzinity based on knee extensor muscle strength. (Nancy Pham)

More from Drug Review Profiles

More from United States